| Literature DB >> 22233833 |
Claudia Sikorski1, Melanie Luppa, Hans-Helmut König, Hendrik van den Bussche, Steffi G Riedel-Heller.
Abstract
BACKGROUND: Primary care practices provide a gate-keeping function in many health care systems. Since depressive disorders are highly prevalent in primary care settings, reliable detection and diagnoses are a first step to enhance depression care for patients. Provider training is a self-evident approach to enhance detection, diagnoses and treatment options and might even lead to improved patient outcomes.Entities:
Mesh:
Year: 2012 PMID: 22233833 PMCID: PMC3266633 DOI: 10.1186/1472-6963-12-10
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Quality assessment (Based on Moncrieff et al., 2001)
| Criterion | Score and rating criteria |
|---|---|
| (1) Objectives and specification | 0 = objectives unclear |
| (2) Adequate sample size (n per group) | 0 = inadequate (< 50/group) |
| (3) Appropriate duration of trial including follow up | 0 = too short (< 3 months) |
| (4) Power calculation | 0 = not reported |
| (5) Method of allocation | 0 = unrandomized and likely to be biased |
| (6) Concealment of allocation | 0 = not done or not reported |
| (7) Clear description of treatments (including doses of drugs used) and adjunctive treatments | 0 = main treatments not clearly described |
| (8) Blinding of subjects | 0 = not done |
| (9) Source of subjects described and representative sample recruitment | 0 = source of subjects not described |
| (10) Use of diagnostic criteria (or clear specification of inclusion criteria) | 0 = none |
| (11) Record of exclusion criteria and number of exclusions and refusals reported | 0 = criteria and number not reported |
| (12) Description of sample demographics | 0 = little/no information (only age/sex) |
| (13) Blinding of assessor | 0 = not done |
| (14) Record of number and reasons for withdrawal by group | 0 = no info on withdrawals by group |
| (15) Outcome measures described clearly (and therefore replicable) or use of validated (or referenced) instruments | 0 = main outcomes not described clearly |
| (16) Information on comparability and adjustment | 0 = no information on comparability |
| (17) Inclusion of all subjects in analyses (Intention to treat analysis) | 0 = no |
| (18) Presentation of results with inclusion of data forre-analysis of main outcomes (for example, SDs) | 0 = little information presented |
| (19) Appropriate statistical analysis (including correction for multiple tests where applicable) | 0 = inadequate |
| (20) Conclusions justified | 0 = no |
| (21) Declaration of interests (for example, 0 = no | 0 = no |
Figure 1Search Strategy.
Study Characteristics
| Study | Country | Recruitment, Inclusion Criteria | Randomization | Na | Intervention, Role of GP Training | Control Group | Comparison | Quality |
|---|---|---|---|---|---|---|---|---|
| Baker (2001) [ | GB | Consecutive patients; ≥ 18 yrs | Practices | 402 | Tailored intervention to promote guideline implementation (additional feedback, educational visits, group discussions) | UCb | Patients of experimental group vs. control group | 30 |
| Bosmans (2006) [ | NL | Consecutive patients; ≥ 55 yrs | Practices | 145 | 4 hrs training session on screening, diagnosis and treatment as in Dutch guidelines | UC | Patients of experimental group vs. control group | 39 |
| Gask (2004) [ | GB | GP referral; | Practice | 189 | Acquisition of clinical skills, 5 lectures à 2 hrs on assessment and treatment; | WL | Patients of experimental group vs. control group | 36 |
| Kendrick (2001) [ | GB | Consecutive patients; | Practice | 733 | Guideline implementation & GP training (4 h seminars, educators available for 9 more mo); | WL | Patients of experimental group vs. control group | 36 |
| King (2002) [ | GB | Consecutive patients; | Practice | 272 | Training of GPs in brief cognitive behaviour therapy (4 half day workshops); | WL | Patients of experimental group vs. control group | 34 |
| Llewellyn-Jones (1999) | AUS | Residential facility; | Patient | 220 | Shared Care Intervention, including GP training & education, health education and promotion, psychoeducation; | WLc | Experimental group vs. control group | 33 |
| Rost (2001) [ | USA | GP referral; | Practice | 479 | QuEST intervention, 4 academic telephone calls to implement guidelines, nurse w/8-hour face-to-face training; | UC | Patients of experimental group vs. control groupd | 38 |
| Worrall (1999) [ | CAN | GP referral; | Practice | 147 | 3-hour sessions on guideline implementation + possible consultation of psychiatrist; | UCb | Patients of experimental group vs. control group | 26 |
a At baseline;b Receipt of guidelines by mail;c Assessment of control group during first period of study, followed by intervention and assessment of experimental group;d Rost et al. (2001): comparison recently treated patients vs. patients beginning new treatment episode, analysis for both intervention groups.
Abbreviations: CES-D - Center for Epidemiologic Studies Depression Scale; CIDI - Composite International Diagnostic Interview; GDS - Geriatric Depression Scale; GP - General Practitioner; HADS-D/A - Hospital Anxiety and Depression Scale; HAM-D - Hamilton Depression Scale; MD - Major Depression; MMSE - Mini Mental Status Examination; mo - month(s); PRIME-MD - Primary care Evaluation of Mental Disorders; QI - Quality Improvement; UC - Usual Care; w/- with; WL - Waiting List; yrs - years.
Study Results
| Study | Follow Up | Attrition Rate %a | Outcome | Results | Limitations | Effect Sizeb |
|---|---|---|---|---|---|---|
| Baker (2001) [ | 16 weeks | 6 | Proportion of patients w/BDI < 11 | Sign. diff in proportion of patients w/BDI > 11 (OR = 2.5) | Tailored intervention that makes GP comparison impossible since they all received diff kinds of intervention | / |
| Bosmans (2006) [ | 12 mo | 21 | PRIME-MD | No sign. diff in MD recovery | Possible Hawthorne effect, less severe episodes of MD in primary care, no blinding of patients | -0.07 |
| Gask (2004) [ | 3, 12 mo | 37 | HAM-D | No sign. diff in scores at both follow up points | Use of a new-onset (depressed less than 6 mo) sample | -0.24 |
| Kendrick (2001) [ | 12 mo | 19 | Hospital Admittance | No sign. difference | Implemented guidelines had been tested in highly selected samples | / |
| Thompson (2000) [ | 6 weeks/6 mo | 50 | HAD | No diff in improvement, no diff in caseness rating at both points | See Kendrick (2001) | / |
| Diagnosis sensitivity | No diff in sensitivity nor specificity | See Kendrick (2001) | / | |||
| King (2002) [ | 6 mo | 10 | BDI | No sign. diff in BDI scores (p = 0.84) | Smaller sample than anticipated | 0.08 |
| Llewellyn-Jones (1999) | 9.5 mo | 23 | GDS | Sign. change in GDS scores | Serial mono-centered design | -0.17 |
| Rost (2001) [ | 6 mo | 10 | mCES-D | Sign. reduction in score in patients beginning new treatment episode | GP training effect unclear, feedback of diagnosis could be responsible for treatment effect | -0.29 |
| Pyne (2003) [ | 12 mo | 65 | Depression severity | Sign. decrease (7.7 units) in experimental group | See Rost (2001) | / |
| Rost (2005) [ | 24 mo | 70 | Depression Free Days | Sign. more depression free days in experimental group (647.6 vs. 558.2) | See Rost (2001) | / |
| Worrall (1999) [ | 6 mo | ? | Gain score CES-D | Sign. improvement in experimental group | Possible Hawthorne effect | -0.22 |
a all groups, last follow up;b calculated as the mean difference of experimental and control group at the latest post-treatment measurement;c adopted from Bower et al. (2006) [45].
Abbreviations: BDI - Beck's Depression Inventory; CBT - Cognitive Behavioral Therapy; CE Ratio - Cost Effectiveness Ratio; mCES-D - (modified) Center for Epidemiologic Studies Depression Scale; CIDI - Composite International Diagnostic Interview; diff - difference; GDS - Geriatric Depression Scale; GP - General Practitioner; HAD - Hospital Anxiety and Depression Scale; HAM-D Hamilton Depression Scale; mo - month(s); MD - Major Depression; PRIME-MD - Primary care Evaluation of Mental Disorders; QALY - Quality of Adjusted Life Year; SF12 - Short Form 12-Item Health Survey; sign - significant
Figure 2Forest-Plot.